Pfizer Comprehensive Income 2012-2026 | PFE

Pfizer comprehensive income for the quarter ending March 31, 2026 was $-8.066B, a 1.19% increase year-over-year.

  • Pfizer comprehensive income for 2024 was $-7.842B, a 1.49% decline from 2023.
  • Pfizer comprehensive income for 2023 was $-7.961B, a 4.13% decline from 2022.
  • Pfizer comprehensive income for 2022 was $-8.304B, a 40.82% increase from 2021.

Pfizer Comprehensive Income 2012-2026 | PFE

  • Pfizer comprehensive income for 2024 was $-7.842B, a 1.49% decline from 2023.
  • Pfizer comprehensive income for 2023 was $-7.961B, a 4.13% decline from 2022.
  • Pfizer comprehensive income for 2022 was $-8.304B, a 40.82% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B